Table 1:
Characteristics | N=199 |
---|---|
Age, years | 72.1 ± 7.6 |
Women | 108 (54%) |
Non-white | 104 (52%) |
Ejection Fraction <45% | 104 (52%) |
BMI, kg/m2 | 33.2 ± 8.8 |
NYHA Class | |
II | 31 (15%) |
III | 104 (52%) |
IV | 44 (22%) |
Patients with previous hospitalization within 6 months | 86 (43%) |
Patients with previous heart failure hospitalizations within 6 months | 53 (32%) |
All-cause hospitalizations within 6 months, total | 165 |
Heart Failure hospitalizations in last 6 months, total | 82 (50%) |
Less than high school education | 37 (19%) |
Live alone | 66 (33%) |
Comorbidities | |
Hypertension | 184 (92%) |
Diabetes mellitus | 110 (55%) |
Atrial fibrillation | 92 (46%) |
Chronic kidney disease | 65 (33%) |
Depression | 33 (17%) |
Stroke | 31 (16%) |
Dementia/Cognitive impairment | 4 (2%) |
Current medications | |
Loop diuretic | 186 (94%) |
Beta blocker | 166 (84%) |
ACE or ARB | 125 (63%) |
Aldosterone antagonist | 36 (18%) |
Digoxin | 13 (13%) |
Physical Function | |
SPPB | 6.0 ± 2.5 |
Balance score | 2.7 ± 1.3 |
4-meter walk score | 2.3 ± 1.0 |
Chair stand score | 1.1 ± 1.1 |
6MWD, meters | 186 ± 100 |
Quality of Life | |
KCCQ OSS | 41 ± 21 |
SF-12 PCS | 28 ± 9 |
SF-12 MCS | 44 ± 14 |
EQ5D-5L | |
Mobility | 2.5 ± 1.0 |
Self Care | 1.7 ± 0.9 |
Usual Activities | 2.6 ± 1.2 |
Pain/Discomfort | 2.4 ± 1.1 |
Anxiety/Depression | 1.8 ± 1.0 |
Thermometer/VAS (0–100) | 57 ± 22 |
Values presented as frequency (%) or mean ± standard deviation unless otherwise indicated.
Abbreviations: BMI, body mass index; ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; SPPB, Short Physical Performance Battery; 6MWD, six-minute walk distance; KCCQ, Kansas City Cardiomyopathy Questionnaire; OSS, Overall Summary Score; SF, Short Form; PCS, physical composite score; MCS, mental composite score; EQ-5D-5L, EuroQol-5D-5L; VAS, visual analog scale.